NDC 16729-288 – Cisplatin
Cisplatin 1 mg/mL · Injection · Intravenous
Product NDC16729-288
Product details
- Brand name
- Cisplatin
- Generic name
- Cisplatin
- Labeler
- Accord Healthcare Inc.
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA206774
- Marketed since
- December 13, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Platinum-based Drug
Active ingredients
- Cisplatin 1 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 16729-288-11 | 50 mL in 1 VIAL (16729-288-11) | Dec 13, 2016 |
| 16729-288-38 | 100 mL in 1 VIAL (16729-288-38) | Dec 13, 2016 |
Recalls mentioning this NDC
- D-0010-2025 Oct 23, 2024 · Class II
Failed Impurities/Degradation Specifications.
Other Cisplatin products
- 60505-6279 Cisplatin 1 mg/mL · Injection, Solution · Apotex Corp.
- 68001-609 Cisplatin 1 mg/mL · Injection, Solution · BluePoint Laboratories
- 68001-608 Cisplatin 1 mg/mL · Injection, Solution · BluePoint Laboratories
- 68001-283 Cisplatin 1 mg/mL · Injection · BluePoint Laboratories
- 72266-253 Cisplatin 1 mg/mL · Injection, Solution · FOSUN PHARMA USA INC
- 72266-252 Cisplatin 1 mg/mL · Injection, Solution · FOSUN PHARMA USA INC
- 63323-103 Cisplatin 1 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 68083-162 Cisplatin 1 mg/mL · Injection, Solution · Gland Pharma Limited
- 68083-163 Cisplatin 1 mg/mL · Injection, Solution · Gland Pharma Limited
- 0143-9505 Cisplatin 1 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9504 Cisplatin 1 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 25021-253 Cisplatin 1 mg/mL · Injection, Solution · Sagent Pharmaceuticals